Date	Event	Description
21 April 2015	Amended	Minor corrections in Figures 6 and 7
25 July 2014	New search has been performed	Searches rerun to January 2014. Three new trials were included, studying flecainide, amiodarone and sotalol. Conclusions of the review did not change
25 July 2014	New citation required but conclusions have not changed	The inclusion of three new trials did not change the conclusions of this review
15 March 2011	New citation required and conclusions have changed	Searches were re‐run for this update to February 2010. Eleven new publications were included. This new trials studied several drugs (amiodarone, azimilide, dofetilide, dronedarone, metoprolol and sotalol) and added 8212 more patients. Some of the conclusions have changed in light of this new evidence: a) Beta‐blockers (metoprolol) showed a significant effect in preventing AF recurrence; b) In addition to class IA drugs, sotalol was also associated with increased all‐cause mortality.
25 February 2011	New search has been performed	Eleven new studies added and results changed
8 September 2008	Amended	Converted to new review format.
23 June 2007	New citation required and conclusions have changed	Substantive amendment